Clinical trial
An Efficacy Trial of The Toolkit for Optimal Recovery After Concussion
NCT07923864 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Efficacy Trial of The Toolkit for Optimal Recovery After Concussion
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2027
- Completion date
- December 31, 2030
- Enrollment
- 260 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety, concussion (diagnosis), mild traumatic brain injury, post concussion symptoms
Arms
As registered; 2 arms.
-
Toolkit for Optimal Recovery after Concussion (TOR-C)
A 4-week mind-body program delivered via live video (Zoom) 1:1 with a clinician delivering mind-body and cognitive-behavioral skills.
-
Health Enhancement after Concussion (HE-C)
A 4-week program delivered via live video (Zoom) 1:1 with a clinician delivering psychoeducation and information about healthy living after a concussion
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Post-Concussion Symptom Scale (PCSS)
Measures the severity of concussion symptoms (e.g., headache, fatigue, dizziness, difficulty concentrating). This is the study's primary outcome; efficacy is judged mainly on reducing these symptoms.
Lead sponsor's other trials
Massachusetts General Hospital, most recent start first.
+2,583 more trials See the organization page
Similar trials
Same condition (Post-Concussion Syndrome) and phase, most recent start first.
+79 more trials See the condition page